MSCs are thought to contribute to tumor progression through pro-angiogenic properties by expressing multiple matrix metalloproteases (MMPs), VEGF and bFGF which degrade the ECM and promote new vessel formation. The gene discussed is VEGFA; the disease is neoplasm.